THROMBIN AND THE THROMBIN THROMBOMODULIN COMPLEX INTERACTION WITH PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1

被引:5
作者
MADDEN, RM
LEVIN, EG
MARLAR, RA
机构
[1] UNIV COLORADO, HLTH SCI CTR,DEPT BIOCHEM,VET ADM MED CTR, LAB SERV 113,1055 CLERMONT AVE, DENVER, CO 80220 USA
[2] UNIV COLORADO, HLTH SCI CTR,DEPT PATHOL,VET ADM MED CTR,LAB SERV, DENVER, CO 80262 USA
[3] UNIV COLORADO, HLTH SCI CTR,DEPT PEDIAT,VET ADM MED CTR,LAB SERV, DENVER, CO 80262 USA
[4] SCRIPPS RES INST, DEPT MOLEC & EXPTL MED, COMM VASC BIOL, LA JOLLA, CA 92037 USA
关键词
FIBRINOLYSIS; PLASMINOGEN ACTIVATOR INHIBITOR TYPE-1; THROMBIN; THROMBOMODULIN; PROTEIN-C;
D O I
10.1097/00001721-199106000-00011
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Thrombin, the final enzyme of the coagulation system, also influences profibrinolytic activity by several mechanisms. These include cellular release of tissue plasminogen activator, activated protein C-induced fibrinolysis, and inactivation of plasminogen activator inhibitor, type 1 (PAI-1). In this report, the role of thrombin in the regulation of PAI-1 is investigated. Our studies demonstrate that thrombin inactivation of PAI-1 occurs via an enzymatic mechanism rather than an enzyme-inhibitor complex mechanism. Evidence to support this conclusion is: (1) concomitant analysis of PAI-1 and thrombin activities demonstrate decreased PAI-1 activity but no loss of thrombin activity; (2) no visible thrombin-PAI-1 complexes by SDS-PAGE analysis; and (3) lack of formation of I-125-thrombin - PAI-1 complexes. Thrombomodulin, a thrombin binding cofactor that modifies thrombin's functions, did not influence the inactivation of PAI-1 by thrombin. We propose that thrombin enzymatically inactivates PAI-1 without forming a stable enzyme-inhibitor complex. The reaction is not affected by thrombomodulin. Overall this reaction occurs so slowly that it is not physiologically relevant without some modifying factor(s).
引用
收藏
页码:471 / 476
页数:6
相关论文
共 50 条
  • [21] Epitopes on plasminogen activator inhibitor type-1 important for binding to tissue plasminogen activator
    Bjorquist, P
    Ehnebom, J
    Inghardt, T
    Deinum, J
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY, 1997, 1341 (01): : 87 - 98
  • [22] The ratio of plasminogen activator inhibitor type-1 activity to the concentration of plasminogen activator inhibitor type-1 protein in diabetes: adding insult to injury
    Sobel, BE
    Neimane, D
    Mack, WJ
    Hodis, HN
    Buchanan, TA
    [J]. CORONARY ARTERY DISEASE, 2002, 13 (05) : 275 - 281
  • [23] INDUCTION OF PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 (PAI-1) BY PROINSULIN AND INSULIN IN-VIVO
    NORDT, TK
    SAWA, H
    FUJII, S
    SOBEL, BE
    [J]. CIRCULATION, 1995, 91 (03) : 764 - 770
  • [24] Evaluation of thrombomodulin/thrombin activatable fibrinolysis inhibitor function in plasma using tissue-type plasminogen activator-induced plasma clot lysis time
    Urano, Tetsumei
    Sano, Yoshie
    Suzuki, Yuji
    Okada, Masahiko
    Sano, Hideto
    Honkura, Naoki
    Morooka, Nanami
    Doi, Matsuyuki
    Suzuki, Yuko
    [J]. RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2024, 8 (04)
  • [25] PARALLEL ANALYSIS OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR AND TYPE-1 PLASMINOGEN-ACTIVATOR INHIBITOR IN PLASMA AND ENDOTHELIAL-CELLS DERIVED FROM PATIENTS WITH CHRONIC PULMONARY THROMBOEMBOLI
    LANG, IM
    MARSH, JJ
    OLMAN, MA
    MOSER, KM
    SCHLEEF, RR
    [J]. CIRCULATION, 1994, 90 (02) : 706 - 712
  • [26] EFFECT OF THROMBIN ON RELEASE OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 FROM CULTURED PRIMATE ARTERIAL SMOOTH-MUSCLE CELLS
    COCKELL, KA
    REN, S
    SUN, J
    ANGEL, A
    SHEN, GX
    [J]. THROMBOSIS RESEARCH, 1995, 77 (02) : 119 - 131
  • [27] THROMBIN REGULATION OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR SYNTHESIS IN CULTURED HUMAN FETAL LUNG FIBROBLASTS
    HAYAKAWA, Y
    TAZAWA, S
    ISHIKAWA, T
    NIIYA, K
    SAKURAGAWA, N
    [J]. THROMBOSIS RESEARCH, 1993, 71 (06) : 457 - 465
  • [28] MEASUREMENT OF PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 ANTIGEN - COMPARISON OF TINTELIZE(TM) AND IMUBIND(TM) METHODS
    STROOP, DM
    GLUECK, CJ
    TRACY, TM
    SCHUMACHER, HR
    [J]. BLOOD COAGULATION & FIBRINOLYSIS, 1994, 5 (06) : 865 - 872
  • [29] Intramural plasminogen activator inhibitor type-1 and coronary atherosclerosis
    Sobel, BE
    Taatjes, DJ
    Schneider, DJ
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2003, 23 (11) : 1979 - 1989
  • [30] Tissue factor, plasminogen activator inhibitor-1, and thrombin receptor expression in human crescentic glomerulonephritis
    Grandaliano, G
    Gesualdo, L
    Ranieri, E
    Monno, R
    Schena, FP
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 35 (04) : 726 - 738